Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 33.49 |
| Open | 33.24 |
| Bid | 29.00 x 800 |
| Ask | 32.15 x 1400 |
| Day's range | 30.07 - 33.37 |
| 52-week range | 15.58 - 78.58 |
| Volume | |
| Avg. volume | 313,579 |
| Market cap | 844.923M |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.04 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 50.57 |
- Simply Wall St.
Analysts Just Shipped A Captivating Upgrade To Their Castle Biosciences, Inc. (NASDAQ:CSTL) Estimates
Castle Biosciences, Inc. ( NASDAQ:CSTL ) shareholders will have a reason to smile today, with the analysts making...
- Zacks
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Castle Biosciences Reports Second Quarter 2022 Results
FRIENDSWOOD, Texas, August 08, 2022--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended June 30, 2022.
© 2022 Yahoo. All rights reserved.
